Nature Reviews Drug Discovery

Medications

New research predicts market share for drug makers

Lagging behind in launching new medicines means a much smaller market share for pharmaceutical companies—even if they spend just as much on advertising, according to new research from Duke University's Fuqua School of Business.

Medications

Drug research and development more efficient than expected

Drug R&D costs have increased substantially in recent decades, while the number of new drugs has remained fairly constant, leading to concerns about the sustainability of drug R&D and question about the factors that could ...

Alzheimer's disease & dementia

Potential Alzheimer's drug prevents abnormal blood clots in the brain

Without a steady supply of blood, neurons can't work. That's why one of the culprits behind Alzheimer's disease is believed to be the persistent blood clots that often form in the brains of Alzheimer's patients, contributing ...

Medications

Targeting drugs to reduce side effects

(Medical Xpress)—Consider ice cream – the base of which is frozen cream. Ingredients are then added to make different flavours. All these flavours are distinctly different but are created from the same foundation.

Medications

Study finds benefit to rapid drug licensing

(Medical Xpress)—Paying too much heed to possible risks when licensing a medication can lead to a pharmaceutical of great benefit to patients either not being licensed or else having its use restricted. For this reason, ...

page 2 from 2